Niclosamide capsules (ANA Therapeutics)

N/A

Report date: 2024/12/02 09:41:12

Base Information

Drug NameNiclosamide capsules (ANA Therapeutics)
Drug Alias NameANA001ANA-001
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionVirus replication inhibitorsWnt signalling pathway inhibitors
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesANA Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesANA Therapeutics
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A